Always supportive and understanding.
Dr Martin Whitehead, MBChB, FRCPA, is a Clinical Senior Lecturer in the Department of Pathology and Biomedical Science at the University of Otago, Christchurch campus. He is categorized under honorary and clinical staff as a Clinical Senior Lecturer. His professional role extends to Anatomical Pathology, where he is listed in the university's Christchurch contact information with a direct dial number and email affiliation through Canterbury Health Laboratories.
Martin Whitehead has co-authored multiple peer-reviewed publications documenting pathology findings in clinical studies. Key publications include "Digital spatial profiling identifies molecular changes involved in the progression of sessile serrated lesions" (Frontiers in Oncology, 2024); "Predicting regression of cervical intraepithelial neoplasia grade 2 in young women: results from the TOPLiNE prospective multicentre trial" (American Journal of Obstetrics and Gynecology, 2022); "CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma" (2020); "Changes in human papillomavirus genotypes associated with progression to high-grade cervical intraepithelial neoplasia" (Papillomavirus Research, 2018); "Coeliac disease in children in Christchurch, New Zealand: Presentation and patterns from 2000-2010" (World Journal of Clinical Pediatrics, 2015); "Observational Management of CIN 2 in Young Women: A Prospective Multicenter Trial" (2016); "Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2" (2020); "Assessment of intratumoural colorectal cancer prognostic biomarkers using NanoString: a pilot study" (Oncotarget, 2019); and "APC Mutations Are Not Confined to Hotspot Regions in Early-Onset Colorectal Cancer" (2020).
